<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">Colorectal cancers</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e>) are classified as having microsatellite instability (MSI) or <z:mp ids='MP_0008866'>chromosomal instability</z:mp> (CIN); herein termed microsatellite stable (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MSS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>MSI <z:hpo ids='HP_0003003'>colon cancers</z:hpo> frequently display a poorly differentiated histology for which the molecular basis is not well understood </plain></SENT>
<SENT sid="2" pm="."><plain>Gene expression and immunohistochemical profiling of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MSS</z:e> and MSI <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell lines and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> revealed significant down-regulation of the intestinal-specific cytoskeletal protein villin in MSI <z:hpo ids='HP_0003003'>colon cancer</z:hpo>, with complete absence in 62% and 17% of MSI cell lines and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, respectively </plain></SENT>
<SENT sid="3" pm="."><plain>Investigation of 577 CRCs linked loss of villin expression to poorly differentiated histology in MSI and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MSS</z:e> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Furthermore, mislocalization of villin from the membrane was prognostic for poorer outcome in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MSS</z:e> patients </plain></SENT>
<SENT sid="5" pm="."><plain>Loss of villin expression was not due to coding sequence mutations, epigenetic inactivation, or promoter mutation </plain></SENT>
<SENT sid="6" pm="."><plain>Conversely, in transient transfection assays villin promoter activity reflected endogenous villin expression, suggesting transcriptional control </plain></SENT>
<SENT sid="7" pm="."><plain>A screen of gut-specific transcription factors revealed a significant correlation between expression of villin and the homeobox transcription factor Cdx-1 </plain></SENT>
<SENT sid="8" pm="."><plain>Cdx-1 overexpression induced villin promoter activity, Cdx-1 knockdown down-regulated endogenous villin expression, and deletion of a key Cdx-binding site within the villin promoter attenuated promoter activity </plain></SENT>
<SENT sid="9" pm="."><plain>Loss of Cdx-1 expression in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> lines was associated with Cdx-1 promoter methylation </plain></SENT>
<SENT sid="10" pm="."><plain>These findings demonstrate that loss of villin expression due to Cdx-1 loss is a feature of poorly differentiated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> </plain></SENT>
</text></document>